FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40383311000001100: Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Jan 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1915381000001114 Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1915391000001111 Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Sotrovimab 500mg/8ml solution for infusion vials true Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial true Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient Sotrovimab false Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient Sotrovimab true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial Has AMP True Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start